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Hansen&u mrakii secretes extracellularly a killer toxin which kills sensitive Saccharomyces cerevisiae. In pro- 
toplasts of this yeast, the killer toxin selectively inhibited the synthesis of alkali-insoluble acid-insoluble 
polysaccharides consisting mainly of @-glucan, but did not inhibit either the synthesis of other cell wall poly 
saccharides, such as mannan, chitin and alkali-insoluble acid-soluble polysa~ha~des, or the synthesis of 
protein. Consistent with these results, the toxin was inhibitory to the /II-( 1,3)-glucan synthetase activity of 
a cell-free extract from sensitive S. cerevisiae. 
Killer toxin (Hansenula mrakii, Yeast) Cell waif /f-(1,3)-G&can 
Protopiast 
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1” INT~GDUCTIG~ 
Killer yeasts secrete killer toxins which kill sen- 
sitive yeasts [I ,2]. Kr killer toxin from certain 
strains of ~accharomyces cerevisiae has been well 
characterized 13-51. It has been found that Ki kiiler 
toxin is coded by a double-stranded RNA plasmid 
[6] with a molecular mass of 1, l-l .4 x lo6 Da [‘?$I 
and that the toxin inhibits pumping of protons in 
sensitive cells f9, IO]. A killer toxin produced by 
K~~~vero~~ce~ la& harboring a linear double- 
stranded DNA plasmid [II] was shown to inhibit 
the adenylate cyclase activity of sensitive yeasts 
1121. Another type of killer toxin from Pichin 
kluyveri was isolated [13] and reported to be in- 
serted into an artificial lipid bilayer with resultant 
formation of pores in the bilayer [ 141. 
Recently we succeeded in raising monoclonal an- 
tibodies against the killer toxin from Hansenula 
mrakii IF0 0895 and applied them to the isolation, 
purification and characterization of the toxin [ 151. 
The purified toxin is a polypeptide with a 
* On leave of absence from Takara Shuzo, Co., Ltd., 
Shimogyo-Ku, Kyoto 600-91, Japan 
molecular mass of 10700 Da composed of 88 
amino acid residues without any carbohydrate 
detectable by Con A reactivity. Various species 
and genera of yeasts have been shown to be suscep- 
tible to the toxin 1161, One of our main interests is 
the mechanism by which the toxin kills such yeasts. 
We report here that the toxin selectively inhibits /3- 
glucan synthesis by sensitive S. cerevisiae in vivo 
and in vitro. 
2. EXFERI~ENTA~ 
2.1. Yeast &rains and media 
The yeast strains employed here were H. mrakii 
killer strain IF0 0895 and S. cerevisiae sensitive 
strain 5059 (diploid, our stock culture). YNBG 
medium contained 0.67% Difco yeast nitrogen 
base and 2% glucose. The regenerating medium 
was 0.67% Difco yeast nitrogen base and 0.8 M 
sorbitol supplemented with 0.5% glucose. 
2.2. ~re~ara~~~~ of killer toxin 
The kilIer toxin was purified by using an affinity 
column of monoclonal antibody [15]. 
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2.3. Cultivation 
Yeast cells were incubated at 30°C in YNBG 
medium and harvested in the logarithmic phase of 
growth. 
2.4. Preparation of yeast protoplasts 
Protoplasts were prepared by treatment of grow- 
ing cells with zymolyase 20T (300/1g/ml, Kirin 
Brewery, Takasaki, Japan) in SE buffer (50 mM 
NazHPOd/NaH2P04, 10mM EDTA, 10 mM 
2-mercaptoethanol, pH 7.6) containing 0.8 M sor- 
bitol for 30 min at 30°C. 
2.5. Incorporation by growing cells and 
protoplasts 
Suspensions of growing cells and protoplasts 
prepared in YNBG medium and regenerating 
medium, respectively (approx. 1 x IO’ cells/ml), 
were incubated at 30°C for the indicated period, 
and then dispensed into tubes which received the 
indicated concentration of the toxin and a specific 
radioisotope. All the tubes were incubated at 30°C 
and, at intervals, samples were withdrawn for frac- 
tionation and radioactive assay as follows: 
(i) Protein synthesis: samples (1.5 ml) taken from 
an incubation mixture containing 0.4 ,&i 
[3,4,5-3H]leucine (120 Ci/mmol) per ml were 
mixed with 0.5 ml of 20% trichloroacetic acid 
and heated at 90°C for 15 min. The trichloro- 
acetic acid-insoluble materials were collected 
on GF/C filters (Whatman). 
(ii) Alkali-insoluble polysaccharide synthesis: 
samples (2.5 ml) withdrawn from an incuba- 
tion mixture containing 0.05 ,&i D-[U-i4C]- 
glucose (270 mCi/mmol) per ml were mixed 
with 0.5 ml of 36% KOH, heated at 80°C for 
90 min, and then the alkali-insoluble materials 
were collected on GF/C filters. 
2.6. Incorporation studies with ceil-free systems 
p-( 1,3)-Glucan synthetase was prepared ac- 
cording to Shematek et al. [17]. The synthesis of & 
glucan in a cell-free system was carried out by the 
methods of Shematek et al. [17] and Lopez- 
Romero and Ruiz-Herrera [ 181. The standard in- 
cubation mixture contained 0.1 mM UDP-[U-‘4C]- 
glucose (1 x 10’ dpm/pmol), 0.16 mM GTP, O.tWo 
bovine serum albumin, 80 mM Tris-chloride 
(pH 7.5), 8.7% glycerol, 5OOpg of cu-amylase per 
ml, 7 mM cellobiose, 5 mM MgC12, 1 mM EDTA 
and enzyme (9Opg protein) in a total volume of 
50~1. Incubation was at 30°C for 60 min with the 
indicated concentration of the killer toxin ranging 
from 1.7 to 207 pg/ml. The reaction was stopped 
with 1 ml of 10% trichloroacetic acid and the 
precipitate was collected on GF/C filters. 
2.7. Fractionation of wall polysaccharides 
A cell suspension was mixed with l/4 vol. of 
30% KOH, heated at 80°C for 90 min and kept at 
4°C for 16 h. To the supernatant obtained after 
centrifugation (3000 x g, 10 min) was added an 
equal volume of Fehling’s solution, and the mix- 
ture was allowed to stand at 0°C for 1 day. The 
precipitate (mannan) was collected on GF/C filters 
(Whatman). The residual (alkali-insoluble) 
materials were washed several times with distilled 
water, resuspended in 0.5 N acetic acid and then 
heated at 100°C for 2 h. The suspension was 
separated into the supernatant @glucan fraction 
1) and the precipitate by centrifugation at 3000 x g 
for 10 min. The precipitate was washed several 
times with phosphate buffer (50 mM KHzPOd/ 
K2HP04, pH 6.3) and treated with 1 mg of 
chitinase (Sigma) per ml in phosphate buffer at 
30°C overnight. The suspension was separated by 
centrifugation at 3000 x g for 10 min into the 
supernatant (chitin) and the residual (&glucan 
fraction 2) fractions. All the fractions were col- 
lected on GF/C filters or directly transferred into 
counting vials for radioactive assay. 
3. RESULTS 
The effect of the toxin on the synthesis of pro- 
tein and alkali-insoluble polysaccharides compris- 
ing principally glucans in growing yeast cells was 
determined by measuring the radioactivity of 
specific precursors taken up by the respective cell 
fractions. The sensitive yeast, S. cerevisiae, was 
grown at 30°C aerobically in YNBG medium, and 
growing cells were harvested from logarithmic 
phase cultures (1 x 10’ cells/ml) and resuspended 
in an equal volume of fresh YNBG medium. After 
incubation at 30°C for a further 15 min, the toxin 
was added to the cell suspension at the final con- 
centrations of 4 and 10 pg/ml, together with an ap- 
propriate amount of a specific isotope. 
The results of a typical experiment are illustrated 
in fig.1. The synthesis of protein in toxin-treated 
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Fig.1. Effect of the killer toxin on biosynthesis of 
cellular constituents by growing cells of S. cerevisiae. A 
cell suspension prepared in YNBG medium (approx. 
1 x lo7 cells/ml) was incubated at 30°C for 15 min, and 
then dispensed into tubes which received 0, 4 or 10 pg of 
the toxin per ml and the indicated concentration of a 
specific radioisotope. All the tubes were incubated at 
30°C and, at intervals, samples were withdrawn for frac- 
tionation and radioactive assay was carried out as 
described in section 2. (0) Control, (a) with 4pg killer 
toxin per ml; (A) with 10 pg killer toxin per ml. 
yeast cells proceeded at a rate similar to that in un- 
treated control cells up to 40 min of incubation 
and then gradually slowed down. On the other 
hand, the synthesis of alkali-insoluble polysac- 
charides was more rapidly and strongly inhibited 
by the toxin, particularly at a concentration of 
lO~g/ml. With this level of the toxin, incorpora- 
tion of ~14C]glucose into the alkali-insoluble poly- 
saccharides fraction was almost completely ar- 
rested by 40 min after the beginning of incubation. 
In toxin (4 or lOpg/ml)-treated cell suspensions, 
none of the cellular components looked for were 
synthesized any longer after 60 min of incubation. 
At this point of incubation, virtually no viable cells 
were recovered from treated cell suspensions by the 
conventional plate count technique. 
As shown in fig.2, the characteristic biological 
activity of the toxin selectively inhibiting the syn- 
thesis of alkali-insoluble polysaccharides, prob- 
ably glucans, was more clearly demonstrated by in- 
corporation studies conducted with protoplasts 
prepared from this yeast. The synthesis of protein 
in yeast protoplasts was not affected by the toxin 
(a) Protein 
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Fig.2. Effect of the killer toxin on the synthesis of 
cellular constituents by S. cerevisiae protoplasts. A pro- 
toplast suspension prepared in regenerating medium (ap- 
prox. 1 x lo7 cells/ml) was incubated at 30°C for 
30 min, and then dispensed into tubes which received 0 
or 4 gg of the toxin per ml and the indicated concentra- 
tion of a specific radioisotope. All the tubes were in- 
cubated at 30°C and, at intervals, samples were with- 
drawn for fractionation and radioactive assay was car- 
ried out as described in section 2. (0) Control, (0) with 
4~8 killer toxin per ml. 
over the 3 h incubation period ifig.2a). In con- 
trast, the synthesis of alkali-insoluble polysac- 
charides in protoplasts was immediately and 
strongly inhibited after the addition of the toxin 
(fig.2b). 
We investigated further whether the toxin selec- 
tively inhibits the synthesis of a specific type of ,L?- 
glucans or also inhibits some other types of yeast 
wall polysaccharides. 
As shown in table 1, in toxin (10 @g/ml)-treated 
S. cefevisiae protoplasts, incorporation of [t4C]- 
glucose into each of three different poiysaccharide 
fractions, namely the mannan fraction, chitin frac- 
tion and alkali-insoluble acid-soluble glucan frac- 
tion (L?-glucan fraction l), was not inhibited but 
rather stimulated. In contrast, incorporation of 
this radioactive precursor into the alkali- and acid- 
insoluble glucan fraction (,8-glucan fraction 2) was 
strongly inhibited. 
The toxin also inhibited in vitro P-(1,3)-glucan 
synthesis in a cellular extract prepared from S. ce- 
fevisiae 5059. The extent of inhibition linearly in- 
creased (from 13 to 66%) in proportion to the con- 
centration of the killer toxin added in the range 
from 1.7 to 207 fig/ml (fig.3). 
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Table 1 
Effect of the killer toxin on incorporation of [r4C]- 
glucose into several wall polysaccharide fractions of 
regenerating protoplasts 
Fraction [‘4C]Glucose incorporated 
(dpm/lO* cells) 
- toxin + toxin 
Mannan 470 500 
Chitin 760 810 
@Glucan 
Fraction 1 940 1470 
Fraction 2 18700 1750 
10 
Killer toxin hg/mO 
Fig.3. Effect of the killer toxin on the &glucan syn- 
thetase reaction catalyzed by a cell-free extract from S. 
cerevisiae. The synthesis of ,&glucan in a cell-free system 
was carried out as described in section 2. The incorpora- 
tion of UDP-[U-14C]glucose into glucan was 2110 dpm 
per sample (control) and 100% inhibition was attained 
with 40 mM glucono$-lactone. 
4. DISCUSSION 
A limited number of papers have been published 
which dealt with the mechanism of action of 
several killer toxins with sensitive yeasts or model 
membrane systems [9,10,12,14]. They indicate that 
Ki killer toxin, a toxin from K. luctis and a toxin 
from P. kluyveri were effective in inhibiting 
proton-pumping in yeast cells, inhibiting the activi- 
ty of yeast adenylate cyclase and formation of 
pores on an artificial lipid bilayer, respectively. On 
the other hand, we were unable to find any of these 
effects in the toxin from H. mrukii (not shown). 
All these results strongly suggest that the 
primary target of action of the H. mrakii toxin is 
in the metabolic processes involving ,&glucan syn- 
thesis in sensitive yeasts. 
The antifungal antibiotics aculeacin A, echino- 
candin B and papulacandin B are all known to be 
specific inhibitors of ,&glucan synthesis in several 
ascomycetous and related deuteromycetous yeasts 
(S. cerevisiae, Schizosaccharomyces pombe and 
Cundidu albicans) [ 19-2 11. These wall-active 
agents not only selectively and strongly inhibit fl- 
glucan synthesis by growing yeast cells, but also in- 
hibit the in vitro activity of P-(1,3)-glucan syn- 
thetase from these yeasts [22]. Thus the bio- 
chemical response of sensitive yeasts to the H. 
mrakii killer toxin appears to be similar to the 
response to aculeacin A and other wall-active 
agents. &Glucan, especially &( 1,3)-glucan, is con- 
sidered the most important structural element of 
the yeast cell wall. Inhibition by the killer toxin of 
,&glucan synthesis may render the wall osmotically 
fragile or defective, ultimately resulting in lytic cell 
death. The mechanism of killing action proposed 
for the H. mrakii killer toxin in this study is unique 
and has never been reported for any other killer 
toxins. 
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